Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Insight Molecular Diagnostics (IMDX) Debt Ratio (2016 - 2026)

Insight Molecular Diagnostics' Debt Ratio history spans 7 years, with the latest figure at 0.02 for Q4 2025.

  • On a quarterly basis, Debt Ratio rose 155.68% to 0.02 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.02, a 155.68% increase, with the full-year FY2025 number at 0.02, up 155.68% from a year prior.
  • Debt Ratio hit 0.02 in Q4 2025 for Insight Molecular Diagnostics, down from 0.02 in the prior quarter.
  • Over the last five years, Debt Ratio for IMDX hit a ceiling of 0.03 in Q4 2023 and a floor of 0.0 in Q3 2022.
  • Historically, Debt Ratio has averaged 0.01 across 5 years, with a median of 0.01 in 2021.
  • Biggest five-year swings in Debt Ratio: tumbled 93.05% in 2022 and later surged 2737.24% in 2023.
  • Tracing IMDX's Debt Ratio over 5 years: stood at 0.01 in 2021, then crashed by 87.48% to 0.0 in 2022, then surged by 2737.24% to 0.03 in 2023, then tumbled by 78.97% to 0.01 in 2024, then skyrocketed by 155.68% to 0.02 in 2025.
  • Business Quant data shows Debt Ratio for IMDX at 0.02 in Q4 2025, 0.02 in Q3 2025, and 0.01 in Q2 2025.